CN106265301A - 含洋甘菊的隔离霜 - Google Patents
含洋甘菊的隔离霜 Download PDFInfo
- Publication number
- CN106265301A CN106265301A CN201610784267.3A CN201610784267A CN106265301A CN 106265301 A CN106265301 A CN 106265301A CN 201610784267 A CN201610784267 A CN 201610784267A CN 106265301 A CN106265301 A CN 106265301A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- skin
- sun screen
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 22
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 20
- 241000628997 Flos Species 0.000 title claims abstract description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 102000008186 Collagen Human genes 0.000 claims abstract description 9
- 108010035532 Collagen Proteins 0.000 claims abstract description 9
- 235000001014 amino acid Nutrition 0.000 claims abstract description 9
- 150000001413 amino acids Chemical class 0.000 claims abstract description 9
- 239000012153 distilled water Substances 0.000 claims abstract description 9
- 239000003921 oil Substances 0.000 claims abstract description 9
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 claims abstract description 8
- 102000003792 Metallothionein Human genes 0.000 claims abstract description 8
- 108090000157 Metallothionein Proteins 0.000 claims abstract description 8
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 8
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 8
- 239000011709 vitamin E Substances 0.000 claims abstract description 8
- 229940046009 vitamin E Drugs 0.000 claims abstract description 8
- 239000000341 volatile oil Substances 0.000 claims abstract description 8
- 241000906543 Actaea racemosa Species 0.000 claims abstract description 7
- 244000178231 Rosmarinus officinalis Species 0.000 claims abstract description 7
- 244000274883 Urtica dioica Species 0.000 claims abstract description 7
- 235000009108 Urtica dioica Nutrition 0.000 claims abstract description 7
- 235000005301 cimicifuga racemosa Nutrition 0.000 claims abstract description 7
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019198 oils Nutrition 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 5
- 239000008169 grapeseed oil Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- -1 Jojoba oil Substances 0.000 claims description 2
- 238000013019 agitation Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229940060184 oil ingredients Drugs 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000010025 steaming Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 12
- 238000002955 isolation Methods 0.000 abstract description 11
- 230000001139 anti-pruritic effect Effects 0.000 abstract description 8
- 239000003908 antipruritic agent Substances 0.000 abstract description 8
- 230000003266 anti-allergic effect Effects 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 206010040880 Skin irritation Diseases 0.000 abstract description 4
- 230000036556 skin irritation Effects 0.000 abstract description 4
- 231100000475 skin irritation Toxicity 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 244000178870 Lavandula angustifolia Species 0.000 description 3
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001835 salubrious effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009967 tasteless effect Effects 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229930007631 (-)-perillyl alcohol Natural products 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241000283222 Physeter catodon Species 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229910000004 White lead Inorganic materials 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001826 anti-prostatic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000005693 perillyl alcohol Nutrition 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种含洋甘菊的隔离霜，其配方中的原料及重量比分别是：金属硫蛋白0.03份、葡萄籽油9份、大刺荨麻5份、紫苏醇5份、洋甘菊提取物20份、迷迭香精油3份、北美升麻3份、薰衣草精油20份、霍霍巴油0.05份、维生素E 1份、胶原蛋白1份、氨基酸0.05份、蒸馏水加至200份。本发明所述各原料的用量和理化性质产生协同作用，从而达到消炎抗过敏、隔离抗氧化的效果。本发明PH值与人体皮肤的PH值接近，对皮肤无刺激性；使用后明显感到舒适、柔软，无油腻感，具有明显的止痒抗炎、隔离护肤的效果。
Description
技术领域
本发明涉及化妆品领域，具体涉及一种消炎抗过敏、隔离抗氧化的含洋甘菊的隔离霜，对皮肤具有良好的止痒抗炎、隔离护肤的效果。
背景技术
隔离霜，是个保护皮肤的重要物品。隔离霜对紫外线确实有隔离作用，而其实质就是防晒。隔离霜中所用的防晒剂和防晒霜中所用是一样，通常分为有机防晒剂，物理防晒剂两类。有机防晒剂和紫外线作用，使原本对肌肤有害的紫外线，转变为无害；物理防晒剂(钛白粉，氧化锌等等)主要是靠折射原理来阻挡紫外线。隔离素具有隔离防晒双重功效，不仅能够阻挡UVA，UVB对肌肤的伤害，预防肌肤晒伤和晒黑，同时隔离和减轻外界环境污染对肌肤的伤害，让肌肤在夏日如青瓜般清爽，透亮。但是涂了隔离霜，如果不仔细卸妆清洁，就会直接导致皮肤晦暗缺乏健康光泽，肤质松弛，滋生暗疮。
发明内容
本发明的目的在于提供一种消炎抗过敏、隔离抗氧化的含洋甘菊的隔离霜，对皮肤具有良好的止痒抗炎、隔离护肤的效果。
本发明采用了这样的技术方案：所述发明适用于任何肌肤的含洋甘菊的隔离霜，其配方中的原料及重量比分别是：金属硫蛋白0.03份、葡萄籽油9份、大刺荨麻5份、紫苏醇5份、洋甘菊提取物20份、迷迭香精油3份、北美升麻3份、薰衣草精油20份、霍霍巴油0.05份、维生素E 1份、胶原蛋白1份、氨基酸0.05份、蒸馏水加至200份。
本发明的重量配比是经过本发明人大量试验获得的，并且在长达2年的实际应用中证明，具有较为理想的止痒抗炎、隔离护肤的效果。
本发明中所述的原料：
金属硫蛋白：(metallothionein)是由微生物和动植物产生的金属结合蛋白，富含半胱氨酸的短肽，对多种重金属有高度亲和性。作用用途：能结合锌和铜，具有重要的神经生理和神经调节功能；治理重金属污染；在体内可以作为补体抗氧化剂.可见，MT在各种疾病的发生及拈抗中发挥着重要的作用；清除自由基的功能使其在抗衰老、抗氧化压力及细胞凋亡等过程中发挥着重要作用。MT是一种潜在的细胞凋亡负调控因子，并且在化疗中对正常机体细胞有一定的保护作用。
葡萄籽油：(Grapeseed Oil)，属于高亚油酸型油脂。葡萄籽油含有丰富的不饱和脂肪酸，主要是油酸和亚油酸。特质；淡黄色或淡绿色，无味、细致、清爽不油腻。作用功效：抗氧化、淡化色斑；调节内分泌失调引起的皮肤干燥，降低黑色素，美白肌肤，祛黄褐斑；刺激细胞分裂与组织再生，活化表层细胞，减少皱纹，延缓衰老；抑制与清除体内自由基，发挥抗癌抗过敏的作用；抗前列腺癌、抗肝脏肿瘤的作用，还可以对抗神经系统的损伤。
大刺荨麻：为双子叶多年生草本植物。作用用途：应用于过敏性鼻炎、风湿病、关节炎、利尿与抗前列腺增生等药用；制造的洗发精，具有抗头皮屑与增进头发的效果。
紫苏醇：(perillyl alcohol)即二氢枯草醇。外观：为无色较稠的液体。香气：温暖的草香，稍有木香和花香。用途：用于仿制柑橘、香草、水果型食用香精和日化香精或制成乙酸酯。紫苏醇的作用可抑制肿瘤发生，逆转已形成肿瘤。对已形成的乳腺癌、胰腺癌、前列腺癌、肝癌等也具有逆转作用。
洋甘菊提取物：外观：棕色粉末。气味：水果香，似苹果的香气。主治功能：止痛，抗过敏，抗抽搐，抗忧郁，止吐，抗发炎，止痒，抗风湿，抗菌，抗痉挛，祛肠胃胀气，促进胆汁分泌，促进结疤，利消化，利尿，柔软皮肤，通经，退烧，利肝，利神经，镇静，利脾，利胃，催汗，补身，驱蠕虫，治创伤。
迷迭香精油：是一种无色至淡黄色挥发性液体。主要功效：具有较强的收敛作用，调理油腻不洁的肌肤，促进血液循环，刺激毛发再生；减轻皮肤充血、浮肿、肿胀；收敛皮肤、改善头皮屑；疏解经痛、利尿、减肥；对胃肠、心、肺、肝、胆都有裨益；强心剂、降血压、调理贫血；提神、醒脑、恢复中枢神经活力；对于减肥后皮肤的收敛，让皮肤更紧实、有弹性。
北美升麻：(Black Cohosh)是一种灌木。主要功效：舒缓风湿症引起的肿痛，帮助身心松弛，解除肌肉痉挛，减轻神经痛，镇咳，并帮助支气管放松，帮助生产过程顺利。
熏衣草精油：(Lavender Oil)，是由薰衣草提炼而成。主要功效：薰衣草搭配多种纯植物精油活性因子相辅相成，快速渗透毛囊消毒抗菌，促进细胞再生，恢复皮肤结缔组织，同时平衡肌肤表层油脂分泌、舒缓敏感肌肤、收敛毛孔、补充肌肤水分，持久保护肌肤不受青春痘粉刺干扰，恢复零毛孔零痘痘的细腻光滑肌肤。
霍霍巴油：主要成分是不饱和高级醇和脂肪酸，有良好的稳定性，极易与皮肤融合，具有超凡的抗氧化性。另外，霍霍巴油还含有丰富维生素，具有滋养软化肌肤的功效。霍霍巴油的成分和海洋中抹香鲸蜡油的成分相似，是其惟一的代用品。其可分解油脂的特性，对出油、粉刺、青春痘皮肤效果极佳。
维生素E：外文名：Vitamin E。是一种脂溶性维生素。其水解产物为生育酚，是最主要的抗氧化剂之一。溶于脂肪和乙醇等有机溶剂中，不溶于水，对热、酸稳定，对碱不稳定，对氧敏感，对热不敏感，但油炸时维生素E活性明显降低。生育酚能促进性激素分泌，使男子精子活力和数量增加；使女子雌性激素浓度增高，提高生育能力，预防流产，还可用于防治男性不育症、烧伤、冻伤、毛细血管出血、更年期综合症、美容等方面。
胶原蛋白：外文名：collagen。生物高分子，动物结缔组织中的主要成分，也是哺乳动物体内含量最多、分布最广的功能性蛋白，占蛋白质总量的25％～30％。与组织的形成、成熟、细胞间信息的传递，以及关节润滑、伤口愈合、钙化作用、血液凝固和衰老等有着密切的关系。胶原蛋白也是生物科技产业最具关键性的原材料之一，在医学材料、化妆品、食品工业等均有着广泛应用。
氨基酸：(amino acid)：含有氨基和羧基的一类有机化合物的通称。性质：无色晶体，熔点极高。同的氨基酸其味不同，有的无味，有的味甜，有的味苦，谷氨酸的单钠盐有鲜味，是味精的主要成分。作用：起氮平衡作用；在医药上主要用来制备复方氨基酸输液，也用作治疗药物和用于合成多肽药物。
蒸馏水：(zhēng liú shuǐ)，是指用蒸馏方法制备的纯水，可分一次和多次蒸馏水。水经过一次蒸馏，不挥发的组分残留在容器中被除去，挥发的组分进入蒸馏水的初始馏分中，通常只收集馏分的中间部分，约占60％。种类可分一次和多次蒸馏水。
本发明所述各原料的用量和理化性质产生协调作用，积极效果在于：消炎抗过敏、隔离抗氧化；PH值与人体皮肤的PH值接近，对皮肤无刺激性；使用后明显感到舒适、柔软，无油腻感，具有明显的止痒抗炎、隔离护肤的效果。
本发明的使用效果实验对比：地址：河南省登封市东关街“某知名品牌美容健身机构”。
第一组：参与实验人数177名，均为某知名品牌美容健身机构女性顾客，年龄18-38岁。使用某企业著名品牌的隔离霜，使用周期为5个月，平均每人每日使用1次。实验结果：满意率68.3％；满意标准：使用后明显感到舒适、柔软，无油腻感，具有明显的滋润养颜效果。
第二组：参与实验人数170名，均为某知名品牌美容健身机构女性顾客，年龄18-42岁。使用本发明所述的含洋甘菊的隔离霜，使用方法是：擦拭于脸部皮肤。使用周期为5个月，平均每人每日使用1次。实验结果：满意率88.7％；满意标准：对皮肤无刺激性，使用后明显感到舒适、柔软，无油腻感，具有明显的止痒抗炎、隔离护肤的效果。
实验对照结果：本发明所述的隔离霜，对皮肤无刺激性，使用后明显感到舒适、柔软，无油腻感，具有明显的止痒抗炎、隔离护肤的效果。
具体实施方式
所述含洋甘菊的隔离霜，其配方中的原料及重量比分别是：金属硫蛋白0.03份、葡萄籽油9份、大刺荨麻5份、紫苏醇5份、洋甘菊提取物20份、迷迭香精油3份、北美升麻3份、薰衣草精油20份、霍霍巴油0.05份、维生素E 1份、胶原蛋白1份、氨基酸0.05份、蒸馏水加至200份。其制备方法是：
步骤一：将金属硫蛋白、北美升麻和蒸馏水混合并加热至85℃，保温搅拌15min，以15r/min的转速搅拌，得溶液备用；
步骤二：将大刺荨麻、洋甘菊提取物、迷迭香精油、薰衣草精油、霍霍巴油、维生素E、葡萄籽油、紫苏醇、氨基酸和胶原蛋白等原料均质10min后加热至85℃，保温并以45r/min的搅拌速度搅拌，在搅拌下将步骤(一)所得溶液加入，待混合均匀后冷却至室温即可。
Claims (2)
1.一种含洋甘菊的隔离霜，其特征在于，配方中的原料及重量比分别是：金属硫蛋白0.03份、葡萄籽油9份、大刺荨麻5份、紫苏醇5份、洋甘菊提取物20份、迷迭香精油3份、北美升麻3份、薰衣草精油20份、霍霍巴油0.05份、维生素E 1份、胶原蛋白1份、氨基酸0.05份、蒸馏水加至200份。
2.按照权利要求1所述的隔离霜，其特征在于，所述含洋甘菊的隔离霜的制备方法是：
步骤一：将金属硫蛋白、北美升麻和蒸馏水混合并加热至85℃，保温搅拌15min，以15r/min的转速搅拌，得溶液备用；
步骤二：将大刺荨麻、洋甘菊提取物、迷迭香精油、薰衣草精油、霍霍巴油、维生素E、葡萄籽油、紫苏醇、氨基酸和胶原蛋白等原料均质10min后加热至85℃，保温并以45r/min的搅拌速度搅拌，在搅拌下将步骤(一)所得溶液加入，待混合均匀后冷却至室温即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610784267.3A CN106265301A (zh) | 2016-08-24 | 2016-08-24 | 含洋甘菊的隔离霜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610784267.3A CN106265301A (zh) | 2016-08-24 | 2016-08-24 | 含洋甘菊的隔离霜 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106265301A true CN106265301A (zh) | 2017-01-04 |
Family
ID=57672447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610784267.3A Pending CN106265301A (zh) | 2016-08-24 | 2016-08-24 | 含洋甘菊的隔离霜 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106265301A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107951830A (zh) * | 2017-12-07 | 2018-04-24 | 广州赛莱拉干细胞科技股份有限公司 | 迷迭香干细胞提取物抗氧化组合物及含该组合物的护肤品 |
| CN113520935A (zh) * | 2021-06-07 | 2021-10-22 | 淮阴工学院 | 彩色多功能隔离霜及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101036630A (zh) * | 2007-04-13 | 2007-09-19 | 孙和平 | 一种用于防辐射的霜剂及其制备方法 |
| CN101249061A (zh) * | 2008-03-17 | 2008-08-27 | 孙和平 | 一种用于解毒消炎的霜剂及其制备方法 |
-
2016
- 2016-08-24 CN CN201610784267.3A patent/CN106265301A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101036630A (zh) * | 2007-04-13 | 2007-09-19 | 孙和平 | 一种用于防辐射的霜剂及其制备方法 |
| CN101249061A (zh) * | 2008-03-17 | 2008-08-27 | 孙和平 | 一种用于解毒消炎的霜剂及其制备方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107951830A (zh) * | 2017-12-07 | 2018-04-24 | 广州赛莱拉干细胞科技股份有限公司 | 迷迭香干细胞提取物抗氧化组合物及含该组合物的护肤品 |
| CN113520935A (zh) * | 2021-06-07 | 2021-10-22 | 淮阴工学院 | 彩色多功能隔离霜及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104188885A (zh) | 一种滋润保湿型紫草润唇膏及其制备方法 | |
| KR20080108718A (ko) | 천연 연화식물체를 포함하는 피부 마사지 화장료 조성물 및그의 제조방법 | |
| CN106473996B (zh) | 一种控油焕肤祛痘修复洗面奶及其制备方法 | |
| CN105106660B (zh) | 一种护肤舒痕的冻疮膏及其制备方法 | |
| US20140248370A1 (en) | Enhancement Composition | |
| CN106176556A (zh) | 一种祛痘控油美白面霜 | |
| CN102836351A (zh) | 一种止痒消肿护肤精华膏及其制备方法 | |
| CN105106655B (zh) | 一种修复性烧伤烫伤膏及其制备方法 | |
| CN109331095A (zh) | 一种祛湿疹组合物及其制备方法 | |
| CN105062726A (zh) | 一款调理肌肤淡化黑色素的药皂 | |
| CN106176323A (zh) | 植物精油美白护肤品 | |
| CN106420558A (zh) | 温和孕妇专用润肤霜 | |
| CN104224599A (zh) | 花青素晒后修复凝露 | |
| CN106333909B (zh) | 一种淡化面部红血丝修复肌肤的乳液及其制备方法 | |
| CN107440995A (zh) | 一种含有中药成分的纯天然唇膏及其制备方法 | |
| CN106265301A (zh) | 含洋甘菊的隔离霜 | |
| CN104188854A (zh) | 营养型滋养无醇收敛水 | |
| CN106994148A (zh) | 一种祛痘中药制剂 | |
| CN106333918A (zh) | 凹凸棒晒后修护面霜 | |
| CN106913486A (zh) | 天然温和美肤日霜 | |
| CN107456567A (zh) | 一种防裂消肿修复滋润的足跟膏及其制备方法 | |
| CN113082195A (zh) | 一种疤痕修复复方精油及其制备方法 | |
| CN100525744C (zh) | 修复霜 | |
| CN105997692B (zh) | 一种止痒消炎保湿除臭的脚膜 | |
| CN105078836A (zh) | 红景天美容润肤霜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170104 |